Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel D Ferrari

Showing results (11-20 of 274) with videos related to

Pageof 28
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|August 12, 2010
[Controversy surrounding the term 'retinal migraine']Joost Haan, Helen van Santbrink, Michel D Ferrari
Brain : a Journal of Neurology|November 30, 2019
Reply: OnabotulinumtoxinA should be considered in medication overuse withdrawal in patients with chronic migraineJudith A Pijpers, Michel D Ferrari, Gisela M Terwindt
Plos One|September 7, 2013
Migraine strikes as neuronal excitability reaches a tipping pointMarten Scheffer, Albert van den Berg, Michel D Ferrari
Current Opinion in Neurology|March 28, 2012
Right-to-left shunts and micro-embolization in migraineHille Koppen, Inge H Palm-Meinders, Michel D Ferrari
Expert Review of Neurotherapeutics|October 9, 2009
Genetic factors in cluster headacheJorine A van Vliet, Michel D Ferrari, Joost Haan
Headache|August 2, 2003
Therapeutic gain or therapeutic ratio?Peter J Goadsby, Michel D Ferrari, Richard B Lipton
The New England Journal of Medicine|January 25, 2002
Migraine--current understanding and treatmentPeter J Goadsby, Richard B Lipton, Michel D Ferrari
Nederlands Tijdschrift Voor Geneeskunde|August 12, 2010
[Preventive treatment for migraine]Wim M Mulleners, Joost Haan, Frans Dekker, et al.
Cerebrovascular Diseases (Basel, Switzerland)|August 7, 2007
Epilepsy in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathyJoost Haan, Saskia A J Lesnik Oberstein, Michel D Ferrari
Trends in Pharmacological Sciences|June 25, 2016
Wiping Out CGRP: Potential Cardiovascular RisksAntoinette MaassenVanDenBrink, Joris Meijer, Carlos M Villalón, et al.
Pageof 28

Showing results (11-20 of 274) with videos related to

Sort By:
Pageof 28
Nederlands Tijdschrift Voor Geneeskunde|August 12, 2010
[Controversy surrounding the term 'retinal migraine']Joost Haan, Helen van Santbrink, Michel D Ferrari
Brain : a Journal of Neurology|November 30, 2019
Reply: OnabotulinumtoxinA should be considered in medication overuse withdrawal in patients with chronic migraineJudith A Pijpers, Michel D Ferrari, Gisela M Terwindt
Plos One|September 7, 2013
Migraine strikes as neuronal excitability reaches a tipping pointMarten Scheffer, Albert van den Berg, Michel D Ferrari
Current Opinion in Neurology|March 28, 2012
Right-to-left shunts and micro-embolization in migraineHille Koppen, Inge H Palm-Meinders, Michel D Ferrari
Expert Review of Neurotherapeutics|October 9, 2009
Genetic factors in cluster headacheJorine A van Vliet, Michel D Ferrari, Joost Haan
Headache|August 2, 2003
Therapeutic gain or therapeutic ratio?Peter J Goadsby, Michel D Ferrari, Richard B Lipton
The New England Journal of Medicine|January 25, 2002
Migraine--current understanding and treatmentPeter J Goadsby, Richard B Lipton, Michel D Ferrari
Nederlands Tijdschrift Voor Geneeskunde|August 12, 2010
[Preventive treatment for migraine]Wim M Mulleners, Joost Haan, Frans Dekker, et al.
Cerebrovascular Diseases (Basel, Switzerland)|August 7, 2007
Epilepsy in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathyJoost Haan, Saskia A J Lesnik Oberstein, Michel D Ferrari
Trends in Pharmacological Sciences|June 25, 2016
Wiping Out CGRP: Potential Cardiovascular RisksAntoinette MaassenVanDenBrink, Joris Meijer, Carlos M Villalón, et al.
Pageof 28